Skip to main content
Log in

Percutaneous hydrodissection for thermoprotection during cryoablation of periureteric and pyeloureteric junction renal cell carcinomas

  • Interventional Radiology
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Objective

To report our experience of percutaneous image-guided cryoablation of renal tumors located within 10 mm of the pyeloureteric junction (PUJ) and/or ureter, with hydrodissection as a stand-alone thermoprotective technique.

Materials and methods

All patients who were offered combined hydrodissection and cryoablation of the PUJ/ureter to treat stage-1 renal cell carcinoma were retrospectively reviewed. Data regarding patients, lesions, and outcomes were collected.

Results

Twenty tumors in 20 patients (13 males:7 females) with a mean age of 74.4 ± 7.5 were included. Mean tumor size was 27.6 ± 6.4 mm. Nearby vulnerable structure(s) were identified as the ureter in 5/20 cases, the PUJ in 8/20 cases and both the PUJ and the ureter in the remaining 7/20 cases (35%) cases. Mean minimal distance between the tumor and the vulnerable organ(s) was 4.8 ± 2.6 mm (range 0–10). A mean of 1.7 ± 0.6 spinal needles were used per intervention with a mean time to complete hydrodissection of 18.6 ± 13.4 min. Primary and secondary technical efficacy rates were 90% and 95%, respectively. Mean follow-up was 23.1 ± 9.2 months. There were no immediate or delayed complications, in particular no urothelial strictures. Two tumor recurrences occurred during follow-up, with a time to disease progression of 13 and 31 months, respectively.

Conclusion

hydrodissection of the PUJ/ureter to prevent thermal injury during cryoablation is an effective technique and does not seem to compromise the efficacy of ablation at short or mid-term follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Andrews JR, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, Callstrom MR, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol. 2019 Aug;76(2):244-251. https://doi.org/10.1016/j.eururo.2019.04.026.

  2. Uhlig J, Strauss A, Rücker G, Seif Amir Hosseini A, Lotz J, Trojan L, et al. Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis. Eur Radiol 2019;29:1293–307. https://doi.org/10.1007/s00330-018-5660-3.

  3. Xing M, Kokabi N, Zhang D, Ludwig JM, Kim HS. Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study. Radiology. 2018 Jul;288(1):81-90. https://doi.org/10.1148/radiol.2018171407.

  4. Breen DJ, King AJ, Patel N, Lockyer R, Hayes M. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma. Radiology 2018;289:554–61. https://doi.org/10.1148/radiol.2018180249.

    Article  PubMed  Google Scholar 

  5. Garnon J, Van Strijen MJ, Nielsen TK, King AJ, Montauban Van Swijndregt AD, Cazzato RL, et al. Safety of percutaneous renal cryoablation: an international multicentre experience from the EuRECA retrospective percutaneous database. Eur Radiol 2019;29:6293–9. https://doi.org/10.1007/s00330-019-06191-y.

  6. Makki A, Aastrup MB, Vinter H, Ginnerup B, Graumann O, Borre M, Nielsen TK. Renal cryoablation - does deep endophytic ablation affect the renal collecting system? Scand J Urol. 2020 Feb;54(1):33-39. https://doi.org/10.1080/21681805.2019.1702094.

  7. Janzen NK, Perry KT, Han KR, Kristo B, Raman S, Said JW, Belldegrun AS, Schulam PG. The effects of intentional cryoablation and radio frequency ablation of renal tissue involving the collecting system in a porcine model. J Urol. 2005 Apr;173(4):1368-74.

  8. Rosenberg MD, Kim CY, Tsivian M, Suberlak MN, Sopko DR, Polascik TJ, Nelson RC. Percutaneous cryoablation of renal lesions with radiographic ice ball involvement of the renal sinus: analysis of hemorrhagic and collecting system complications. AJR Am J Roentgenol. 2011 Apr;196(4):935-9. https://doi.org/10.2214/AJR.10.5182.

  9. Bagley DH, Terrill R, Javadpour N, Beazley RM. Cryosurgery of the ureter in dogs. Invest Urol 1976;14:241–5.

    CAS  PubMed  Google Scholar 

  10. Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol 2005;185:72–80. https://doi.org/10.2214/ajr.185.1.01850072.

    Article  PubMed  Google Scholar 

  11. Garnon J, Cazzato RL, Caudrelier J, Nouri-Neuville M, Rao P, Boatta E, Ramamurthy N, Koch G, Gangi A. Adjunctive Thermoprotection During Percutaneous Thermal Ablation Procedures: Review of Current Techniques. Cardiovasc Intervent Radiol. 2019 Mar;42(3):344-357. https://doi.org/10.1007/s00270-018-2089-7.

  12. West B, Keheila M, Smith JC, Erskine A, Abourbih SR, Khater N, Baldwin DD. Efficacy of antegrade and retrograde warm saline pyeloperfusion during renal cryoablation for ureteral preservation. Turk J Urol. 2018 Mar;44(2):142-147. https://doi.org/10.5152/tud.2017.44380.

  13. Mauri G, Nicosia L, Varano GM, Bonomo G, Della Vigna P, Monfardini L, Orsi F. Tips and tricks for a safe and effective image-guided percutaneous renal tumour ablation. Insights Imaging. 2017 Jun;8(3):357-363. https://doi.org/10.1007/s13244-017-0555-4.

  14. Zhao Y, Matsui Y, Hiraki T, Iguchi T, Masaoka Y, Kanazawa S. Six Cases of Radiographic Ice Ball Involvement of the Ureter During Percutaneous Cryoablation for Renal Cancers. Cardiovasc Intervent Radiol. 2020 Feb;43(2):344-346. https://doi.org/10.1007/s00270-019-02358-8.

  15. Hwang SI, Cho JY, Kim SH, Jun SR, et al. Protection of the renal collecting system during radiofrequency ablation with antegrade cold dextrose infusion. Radiology. 2010;256(3):759–66. https://doi.org/10.1148/radiol.10091220.

  16. Eswara JR, Gervais DA, Mueller PR, Arellano RS, et al. Renal radiofrequency ablation with pyeloperfusion. Int J Urol. 2015;22(1):131–2. https://doi.org/10.1111/iju.12625.

    Article  PubMed  Google Scholar 

  17. Dai Y, Covarrubias D, Uppot R, Arellano RS. Image-guided percutaneous radiofrequency ablation of central renal cell carcinoma: assessment of clinical efficacy and safety in 31 tumors. J Vasc Interv Radiol. 2017;28(12):1643–50. https://doi.org/10.1016/j.jvir.2017.05.006 .

  18. Khan F, Ho AM, Jamal JE, Gershbaum MD, et al. Long-term outcomes after percutaneous renal cryoablation performed with adjunctive techniques. Clin Imaging. 2017;12(50):62–7. https://doi.org/10.1016/j.clinimag.2017.12.003.

  19. Hebbadj S, Cazzato RL, Garnon J, Shaygi B, Buy X, Tsoumakidou G, Lang H, Gangi A. Safety Considerations and Local Tumor Control Following Percutaneous Image-Guided Cryoablation of T1b Renal Tumors. Cardiovasc Intervent Radiol. 2018 Mar;41(3):449-458. https://doi.org/10.1007/s00270-017-1820-0.

  20. Patel IJ, Rahim S, Davidson JC, Hanks SE, Tam AL, Walker TG, Wilkins LR, Sarode R, Weinberg I. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-Part II: Recommendations: Endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol. 2019 Aug;30(8):1168-1184.e1. https://doi.org/10.1016/j.jvir.2019.04.017.

  21. Krokidis ME, Orsi F, Katsanos K, Helmberger T, Adam A. CIRSE Guidelines on Percutaneous Ablation of Small Renal Cell Carcinoma. Cardiovasc Intervent Radiol. 2017 Feb;40(2):177-191. https://doi.org/10.1007/s00270-016-1531-y.

  22. Georgiades C, Rodriguez R, Azene E, et al. Determination of the nonlethal margin inside the visible "ice-ball" during percutaneous cryoablation of renal tissue. Cardiovasc Intervent Radiol. 2013;36(3):783–790. https://doi.org/10.1007/s00270-012-0470-5

    Article  PubMed  Google Scholar 

  23. Buy X, Lang H, Garnon J, Sauleau E, Roy C, Gangi A. Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors. AJR Am J Roentgenol. 2013 Dec;201(6):1353-61. https://doi.org/10.2214/AJR.13.11084.

  24. Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, Chen MH, Choi BI, de Baère T, Dodd GD 3rd, Dupuy DE, Gervais DA, Gianfelice D, Gillams AR, Lee FT Jr, Leen E, Lencioni R, Littrup PJ, Livraghi T, Lu DS, McGahan JP, Meloni MF, Nikolic B, Pereira PL, Liang P, Rhim H, Rose SC, Salem R, Sofocleous CT, Solomon SB, Soulen MC, Tanaka M, Vogl TJ, Wood BJ, Goldberg SN; International Working Group on Image-Guided Tumor Ablation; Interventional Oncology Sans Frontières Expert Panel; Technology Assessment Committee of the Society of Interventional Radiology; Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. J Vasc Interv Radiol. 2014 Nov;25(11):1691–705.e4. https://doi.org/10.1016/j.jvir.2014.08.027.

  25. Garnon J, Schlier A, Buy X, Tsoumakidou G, de Mathelin M, Breton E, Gangi A. Evaluation of percutaneous biopsies of renal masses under MRI-guidance: a retrospective study about 26 cases. Eur Radiol. 2015 Mar;25(3):617-23. https://doi.org/10.1007/s00330-014-3449-6.

  26. Isfort P, Penzkofer T, Tanaka T, Bruners P, Westphal S, Kennes LN, Schmitz-Rode T, Kuhl CK, Mahnken AH. Efficacy of antegrade pyeloperfusion to protect the renal pelvis in kidney microwave ablation using an in vivo swine model. Invest Radiol. 2013 Dec;48(12):863-8. https://doi.org/10.1097/RLI.0b013e3182a2af82

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julia Weiss.

Ethics declarations

Conflict of interest

Julien Garnon & Afshin Gangi are proctors for BTG Galil. All other authors have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weiss, J., Garnon, J., Cazzato, R.L. et al. Percutaneous hydrodissection for thermoprotection during cryoablation of periureteric and pyeloureteric junction renal cell carcinomas. Abdom Radiol 46, 1179–1187 (2021). https://doi.org/10.1007/s00261-020-02760-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-020-02760-8

Keywords

Navigation